U-Neuron Biomedical (ROCO:6973) Ending Cash Position : NT$56.96 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Ending Cash Position?

U-Neuron Biomedical's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$56.96 Mil.

U-Neuron Biomedical's quarterly Ending Cash Position declined from Dec. 2022 (NT$31.02 Mil) to Jun. 2023 (NT$30.13 Mil) but then increased from Jun. 2023 (NT$30.13 Mil) to Dec. 2023 (NT$56.96 Mil).

U-Neuron Biomedical's annual Ending Cash Position declined from Dec. 2021 (NT$55.52 Mil) to Dec. 2022 (NT$31.02 Mil) but then increased from Dec. 2022 (NT$31.02 Mil) to Dec. 2023 (NT$56.96 Mil).

U-Neuron Biomedical Ending Cash Position Historical Data

The historical data trend for U-Neuron Biomedical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Ending Cash Position Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

55.52

31.02

56.96

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	-	26.67	31.02	30.13	56.96

U-Neuron Biomedical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

U-Neuron Biomedical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	31.016	+	25.941
	=	56.96

U-Neuron Biomedical's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	30.125	+	26.832
	=	56.96

U-Neuron Biomedical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines